The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders

  • Major mood disorders, which primarily include bipolar disorder and major depressive disorder, are the leading cause of disability worldwide and pose a major challenge in identifying robust risk genes. Here, we present data from independent large-scale clinical data sets (including 29 557 cases and 32 056 controls) revealing brain expressed protocadherin 17 (PCDH17) as a susceptibility gene for major mood disorders. Single-nucleotide polymorphisms (SNPs) spanning the PCDH17 region are significantly associated with major mood disorders; subjects carrying the risk allele showed impaired cognitive abilities, increased vulnerable personality features, decreased amygdala volume and altered amygdala function as compared with non-carriers. The risk allele predicted higher transcriptional levels of PCDH17 mRNA in postmortem brain samples, which is consistent with increased gene expression in patients with bipolar disorder compared with healthy subjects. Further, overexpression of PCDH17 in primary cortical neurons revealed significantly decreased spine density and abnormal dendritic morphology compared with control groups, which again is consistent with the clinical observations of reduced numbers of dendritic spines in the brains of patients with major mood disorders. Given that synaptic spines are dynamic structures which regulate neuronal plasticity and have crucial roles in myriad brain functions, this study reveals a potential underlying biological mechanism of a novel risk gene for major mood disorders involved in synaptic function and related intermediate phenotypes.

Download full text files

Export metadata

Metadaten
Author:Hong Chang, Naosuke Hoshina, Chen Zhang, Yina Ma, Hongxin Cao, Yaling Wang, Dong-Dong Wu, Sarah E. Bergen, Mikael Landén, Christina M. Hultman, Martin Preisig, Zoltán Kutalik, Enrique Castelao, Maria Grigoroiu-SerbanescuORCiD, Andreas Josef Forstner, Jana Strohmaier, Julian Hecker, Thomas G. Schulze, Bertram Müller-Myhsok, Andreas ReifORCiDGND, Philip B. MitchellORCiD, Nicholas Gordon Martin, Peter R. SchofieldORCiD, Sven Cichon, Markus Maria Nöthen, Henrik Walter, Susanne Erk, Andreas Heinz, Najaf Amin, Cornelia M. van Duijn, Andreas Meyer-Lindenberg, Heike Tost, Xiao Xiao, Tadashi Yamamoto, Marcella RietschelORCiDGND, Ming Li
URN:urn:nbn:de:hebis:30:3-491435
DOI:https://doi.org/10.1038/mp.2016.231
ISSN:1476-5578
ISSN:1359-4184
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/28070120
Parent Title (English):Molecular psychiatry
Publisher:Macmillan
Place of publication:London
Document Type:Article
Language:English
Year of Completion:2017
Date of first Publication:2017/01/10
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Contributing Corporation:The Swedish Bipolar Study Group ; MooDS Bipolar Consortium
Release Date:2019/02/21
Tag:Bipolar disorder; Depression; Genetics; Neuroscience
Volume:23
Issue:2
Page Number:13
First Page:400
Last Page:412
Note:
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
HeBIS-PPN:446276154
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 4.0